Let’s get closer! Visit our booth at RSNA 2022 to discuss how we can push the limits of image quality in ultrasound and X-ray – together.
https://t.co/sELDdTBqE6
#RSNA22#RSNA2022@RSNA#MEDTECH#INNOVATION
A great quarterly report.
With a consistent focus on our core business, we managed to deliver yet another successful quarter. Thanks to the great ContextVision team and our valued customers for making it happen! Link to pressrelease: https://t.co/JmgCigtZUS
Rivent 3D combines the benefits of volumetric processing with unique capabilities to process images powerfully while maintaining a natural appearance. By analyzing data in all dimensions Rivent 3D takes image quality to a level beyond conventional 2D enhancement technology.
Today, Monday, at 16:00CET, Dr Yildiz will present results from a clinical evaluation where the ability of INIFY Prostate to improve accuracy, concordance and diagnostic confidence among pathologists was studied. Listen in to find out what effects it had!
https://t.co/smHq3jsNq9
With Rivent 3D, ContextVision now expands the Rivent platform further and provides clinicians with 3D and 4D images with clarity close to reality, supporting them in providing confident diagnosis and better treatment. https://t.co/j1CbxUrvm1
#ultrasound#medicalimaging
Join us at RSNA! Listen to our Application Engineer as he talks about how varying image quality in radiography can be addressed through AI-Powered Image Enhancement. Go to event here: https://t.co/gRxlRvCLK3
#RSNA21
Today at 16:55, at the #DigiPathGE , Dr Adam will share his experience of working with INIFY. Unfortunately we could not join on site this year, but we wish all the participants an excellent and safe congress and we hope to see you all again next year.
#PathTwitter
Join us at RSNA 2021! Fredrik Palm (CEO) and the ContextVision team present our vision for a new generation of image enhancement for ultrasound. Watch the presentation: https://t.co/6cSXDfjwuF
#RSNA21#Ultrasound
It's #Movember2021, raising awareness of #prostatecancer For us, the focus is on improving prostate cancer diagnostics 365 days/year. INIFY® provides pathologists with valuable decision support for prostate biopsies. This can ease the workload & contribute to better #cancercare
ContextVision has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology. Read more at: https://t.co/b9pughoyHG
#digitalpathology#medicalimaging
INIFY Prostate® shown to accurately outline suspicious prostate cancer in study with two prominent medical centers. Read more at: https://t.co/mhhflqKMIV
#DigitalPathology#Pathology#AI#ProstateCancer#INIFY